|
|
REGIONAL REIMBURSEMENT CONTACTS
Abbvie
Samantha Neville
Field Access Specialist - Northeast
Cell:(727) 401-9924
Venclexta https://www.venclexta.com/cll/support-and-resources/financial-support.html
Adaptive Biotechnologies
Karuna Craig
Patient Access and Reimbursement Manager
kcraig@adaptivebiotech.com
Patient Hotline (855) 236 9230
Clinical Services (888) 552-8988
https://www.clonoseq.com/adaptive-assist
Agios Pharmaceuticals
Farida Ayub, Patient Support Manager
Farida.ayub@agios.com
(617) 340-3917
My Agios Patient Services
Alexion
Jen Ulven
Field Reimbursement Manager
1-904-874-3344
Jen.Ulven@Alexion.com
Ultomiris, Soliris
AMAG Pharmaceuticals
Feraheme Assist
Feraheme IV Iron
Mariaelena Galie
Senior Manager, Patient Services
267-275-1185
https://www.feraheme.com/patient-support/
Amgen
Amy Zhan
Cell 908-894-3385
Toll free: 844-889-9222 Option 3, Option 1, Extension 1
Email; amy.zhan@syneoshealth.com
Amgen Support Plus
https://www.amgensupportplus.com/
Apellis
Rotsalinh Hellert
Field Access Manager – Northeast
Phone- 617-917-9405
Rotsalinh.hellert@apellis.com
https://empavelihcp.com/#
Melissa Mewes
Associate Director, Field Access
Phone: 503-913-8547
Melissa.Mewes@apellis.com
Astellas
Kevin Kobylinski
Access and Reimbursement Manager
NH/VT/ME/MA/CT/RI/NY
C: 603-502-8175
E-mail: kevin.kobylinski@Astellas.com
PADCEV® (enfortumab vedotin-ejfv), Xospata® (gilteritinib), Xtandi® (enzalutamide), VYLOY® (zolbetuximab-clzb)
https://www.astellaspharmasupportsolutions.com/
AstraZeneca/MedImmune
Jenifer N. McNulty
Field Reimbursement Manager
MA, ME, NH, VT, RI
Cell 617.818.3517
jenifer.mcnulty@astrazeneca.com
Imfinzi, Tagrisso, Lynparza, Calquence, Faslodex, Imjudo, Iressa, Enhertu, Truqap, Datroway
Joann Dousa, RPh, AE-C
Field Reimbursement Manager, Oncology
Connecticut, Upstate New York, Western MA
Cell: 508-813-2834
Joann.Dousa@astrazeneca.com
Imfinzi, Tagrisso, Lynparza, Calquence, Faslodex, Imjudo Iressa, Enhertu, Truqap, Datroway
My Access 360 | Helping Patients Access the Care They Need
Aveo Oncology
Kathleen Goulette
Oncology Account Manager-New England
KGoulette@aveooncology.com
978.337.3511
Product: Fotivda (tivozanib)
AVEO ACE Program- Access Center of Excellence
www.fotivda.com to enroll
1-833-Fotivda (1-833-368-4832)
Nicole Artz
Associate Director Field Reimbursement – Oncology
Northeast Region
Nicole.artz@bayer.com
781-561-6587
Nubeqa, Xofigo, Stivarga, Vitrakvi, Hyrnuo
Nubeqa Patient Assistance
Xofigo Patient Assistance
Stivarga Patient Assistance
Vitrakvi Patient Assistance
HYRNUO Patient Assistance
BeOne
Dusti Prisock
Director of Payer Accounts
Email: dusti.prisock@beonemed.com
Mobile: 404-386-0249
Brukinsa Patient Support
1-833-234-4363
Patient Access: https://www.mybeonesupport.com/
Brukinsa
Blueprint Medicines
Fred Richards
Associate Director, Regional Marketing
New England and New York
Blueprint Medicines
Frichards@blueprintmedicines.com
Cell# 781-258-1457
Blueprint Medicines Global Headquarters
45 Sidney Street
Cambridge, MA 02139
Ayvakit (avapritinib) Indicated for: Systemic Mastocytosis (Indolent SM, Smoldering SM, Advanced SM, SM with AHN), and PDGFRA GIST
Ayvakit Product Information: https://ayvakit.com/
Ayvakit Patient Support Programs: https://yourblueprint.com/
Unbranded/Disease Awareness: https://itssmthing.com/
Gavreto (pralsetinib) – Indicated for: RET+ mNSCLC and RET+ advanced or metastatic thyroid carcinoma
Gavreto Product Information: https://www.gavreto.com/
Bristol Myers Squibb Access Support
Mathew Regan
Enterprise Access & Reimbursement Manager
Northern New England (Maine, New Hampshire, and Vermont)
Cell (603) 391-7864
Oncology
Abraxane, Opdivo, Opdualag, Yervoy
Hematology
Empliciti, Idhifa, Inrebic, Onureg, Pomalyst, Reblozyl, Revlimid, Sprycell
Peter Ferreira-Gandolfo M.B.A.
Cell Therapy Market Access Manager, Products: Breyanzi and Abecma
Northeast | US Cell Therapy Market Access
Mobile 1-(617) 477-7434
Boehringer-Ingelheim
Susan Salcito
Field Reimbursement Manager
Cell Phone: 203-592-3134
E-mail: susan.salcito@boehringer-ingelheim.com
Hernexeos: HERNEXEOS
HERNEXEOS Co-Pay Assistance
Gilotrif: https://www.gilotrifhcp.com/starting-your-patient
Gilotrif Commercial Co-Pay
For more information on the BI Cares Foundation, call 1-855-297-5906 or visit www.boehringer-ingelheim.us/our-responsibility/patient-assistance-program
Amy Fleming
Account Manager
Mobile: 413-530-0069
Email: afleming@carisls.com
Patient Access Page: https://www.carislifesciences.com/patients/
Patient Financial Services: https://www.carislifesciences.com/patients/financial-services/
Clovis Oncology
Katheryne Murray
Practice Experience Manager- Northeast
Cell: 860-876-5568
Rubraca® (rucaparib)
Coherus Biosciences, Inc.
Jo Ann Escanlar
Director, Field Reimbursement
469-797-9809
Charlie Flynn
Associate Director of Reimbursement for Northeast
Daiichi Sankyo
211 Mount Airy Drive
Basking Ridge, NJ 07920
Work (410) 688-4109
Email - charles.flynn@daiichisankyo.com
Products- Enhertu, Vanfltya, Injectafer, Turalio
https://dsiaccesscentral.com/hcp/vanflyta-/financial-help/copay
https://www.injectafercopay.com/hcp/login
Dova Pharmaceuticals
Richard DeBone
Director- Market Access
Dova Pharmaceuticals
rdebone@dova.com
724.953.9661
RJ Valera
Oncology Lead, Access & Reimbursement
Eisai Inc.
200 Metro Blvd
Nutley, NJ 07710
Office Tel: (201)746-2115
Lenvima and Halaven
Eisai Assistance Program
For program and eligibility information, and to review the program terms and conditions, please visit, https://www.eisaipatientsupport.com/hcp/lenvima/patient-support or call 1-866-61-EISAI (1-866-613-4724)
EMD Serono
Walter Serafin, MA, BA
Associate Director, Field Patient Services - Oncology
EMD Serono, Inc.
Mobile: (339) 214-6080
Office: (913) 322-6063
One Technology Place
For Bavencio:
CoverOne.com
Phone: (844) Cover1 or (844) 826-8371
Monday-Friday: 8:00am-8:00pm ET
For Tepmetko:
OncNavigationCenter.com
Phone: 1-844-662-3631 (844-ONC-EMD1)
Fax: 844-501-0062
Monday–Friday: 8:00 am–8:00 pm ET
Exelixis
Michele Sofarelli Luther
Patient Access Director
CABOMETYX.com
207-838-2364
msofarelli@exelixis.com
Exelixis Access Services
Foundation Medicine
Janna Dyer RN, BSN, OCN
Cell: 207-590-3834
Foundation Access Program: https://www.foundationmedicine.com/patient/financial-support-resources
Genomic included in the Foundation Access Program: FoundationOne CDx, FoundationOneLiquid CDx, FoundationOne Heme, PDL1 and IHC tests
Cell: 475-254-6532
E-mail: Villarreal.Paul@gene.com
https://www.genentech-access.com
copayassistancenow.com
https://www.gene.com/patients/patient-foundation
855-MYCOPAY (855-692-6729)
Infused Products: AVASTIN® (bevacizumab) , GAZYVA® (obinutuzumab)HERCEPTIN® (trastuzumab), KADCYLA® (ado-trastuzumab emtansine), PERJETA® (pertuzumab), POLIVY™ (POLATUZUMAB VEDOTIN-PIIQ), RITUXAN® (rituximab), TECENTRIQ® (atezolizumab)
Oral Products: ALECENSA® (alectinib), COTELLIC® (cobimetinib), ERIVEDGE® (vismodegib),GAVRETO (pralsetinib),ROZLYTREK® (entrectinib), TARCEVA® (erlotinib), VENCLEXTA™ (venetoclax) ZELBORAF® (vemurafenib)
Subcutaneous Products: HERCEPTIN HYLECTA™ (TRASTUZUMAB AND HYALURONIDASE-OYSK), PHESGO (pertuzumab, trastuzumab, and hyaluronidase-zzxf), RITUXAN HYCELA™ (rituximab/hyaluronidase human)
Genmab US, Inc.
David R Taylor
Associate Director, Field Reimbursement
1-609-455-3411
dtay@genmab.com
http://www.mynavcare.com
Epkinly
Genomic Health
Dan Monteith
Regional Oncogenomic Liaison
Genomic Health
m 650.722.7043 or 866.613.3015
f 603.488.5565
dmonteith@genomichealth.com
Geron Corporation
Kathy Lindner RD, CPB
Director, Field Reimbursement & Access (Northeast)
Geron Corporation
Mobile: 302-593-9735 | Office: 302-593-9735
Email: klindner@geron.com
Gilead
Melissa McLean
Field Reimbursement Senior Manager (Northeast)
M: (914) 715-7535
Email: melissa.mclean1@gilead.com
Zydelig (idelalisib)
https://www.zydeligaccessconnect.com/patient
1-844-622-2377
Yescarta (axicabtagene ciloleucel)
https://www.yescarta.com/support#kite-konnect
1-844-454-5483
Trodelvy/Gilead
Access Services: https://www.gileadoncologysupport.com/
GlaxoSmithKline
Michael Savoia
Northeast Oncology FRM
Managed Markets & Government Affairs
5 Moore Drive, PO Box 13398, RTP, NC 27709-3398
United States
Email michael.j.savoia@gsk.com
Cell 914-588-3473
www.togetherwithgskoncology.com
GT Medical Technologies, Inc.
Reimbursement Support
1.833.662.0044
Julie Garfield
Dakota Fog
dfog@gtmedtech.comGuardant Health
Joana Buxhaku
Mobile +1-781-219-8511
Client Services 855-698-8887
Patient Program: Guardant Access Program https://guardanthealth.com/precision-oncology/for-patients/
Genomic tests included in the Guardant Access Program:
Guardant360 CDx
Guardant360
Guardant360 TissueNext + PDL1
Guardant360 Response
Guardant Reveal
Heron Therapeutics
Michelle Wollersheim
Director, National Accounts /Reimbursement
C: 414-687-5624
E: mwollersheim@herontx.com
CINVANTI® (aprepitant) injectable emulsion
SUSTOL® (granisetron) extended-release injection
Marcy Gingerich
Field Access Manager, McKesson
740-405-2240
Marcy.Gingerich@McKesson.com
Jakafi (ruxolitinib)
Pemazyre (pemigatinib)
Zynyz (retifanlimab-dlwr)
Niktimvo (Axatilimab)
855-452-5234
Monjuvi (tafasitamab-cxix)
855-421-6172
Immunocore
Karen Smith
Associate Director, Patient Access and Reimbursement (North East)
Mobile: (617) 320-0378
Email: karen.smith@immunocore.com
KIMMTRAK® (tebentafusp-tebn) - Official Website
KIMMTRAK (tebentafusp-tebn) | Savings program | Patient Resources | KIMMTRAK
Ipsen
Melissa Kramer
Regional Reimbursement Director
978-701-8568
Email:melissa.kramer@ipsen.com
Lorna Aouad
Oncology Associate Specialist
925–967–5620
Lorna.aouad@ipsen.com
Somatuline Depot(Lanreotide), and Onivyde(Irinotecan Liposome Injection)/ Nalirifox (1L indication for mPDAC includes Onivyde in the regimen) and Tazverik (tazmetostat)
Patient Access services: www.ipsencares.com
Janssen
Ward Bennett
Healthcare Policy and Advocacy Director
Strategic Customer Group
Johnson & Johnson
Health Care Systems Inc.
8 Bloody Brook Rd
Amherst NH 03031 USA
T: 603-672-9381
M: 603-345-1404
wbennett@its.jnj.com
http://www.janssencarepath.com/
DARZALEX® (daratumumab), YONDELIS® (trabectedin), ZYTIGA® (abiraterone acetate), DOXIL® (doxorubicin HCl liposome injection), PROCRIT® (epoetin alfa), and SYLVANT® (siltuximab),ERLEADA® (apalutamide).
Janssen CompassTM support program dedicated to patients who have been prescribed either ERLEADA® (apalutamide), DARZALEX® (daratumumab), or DARZALEX Faspro® (daratumumab and hyaluronidase-fihj) https://www.janssencompass.com
Jazz Pharmaceuticals
Lynn Monte
Access & Reimbursement Manager
Hematology/Oncology
Jazz Pharmaceuticals
3170 Porter Drive
Palo Alto, CA 94304
508-873-1445
Lynn.monte@jazzpharma.com
www.jazzcares.com
Jacqueline Buckley
Corporate Account Director
85 Wells Avenue Suite 210
Newton MA 02459
Cell: 774- 236-0231
jbuckley@karyopharm.com
XPOVIO® (selinexor)
For HCPs: www.XPOVIOpro.com
https://www.karyforward.com
Kite Pharma
Bonnie Moxhay
Key Account Director
Bmoxhay@kitepharma.com
Large B-Cell Lymphoma | YESCARTA® (axicabtagene ciloleucel)
https://www.kitepharma.com/Let’s Chat CAR T unbranded program here
Steven McRae
Market Access Leader, Northeast Region
Cell: (908) 812-8938
steven.mcrae@lantheus.com
PYLARIFY Reimbursement Support: https://www.pylarify.com/ordering-and-reimbursement
PYLARIFY Support Hotline telephone number 1-844-339-8514
Lilly USA
Beth Finnerty
Oncology Field Reimbursement Manager – Northeast
Eli Lilly and Company
Ph: 716-261-7627
email: finnerty_beth@lilly.com
https://www.lillyoncologysupport.com
Cyramza (ramucirumab), Alimta (pemetrexed), Erbitux (cetuximab),Retevmo (Selpercatinib), Verzenio (abemaciclib), Portrazza (necitumumab), Jaypirca (pirtobrutinib)
Verzenio Continuous Care Program
Verzenio.com
1-844-verzenio (1-844-837-9364)
Lilly Cares Foundation
Lillycares.com
1-800-545-6962
Merck
Field Reimbursement
Erin Pittsley
erin.pittsley@merck.com
+1 (508) 7175146
Mark Montello
Medicare Account Executive
Mark.Montello@merck.com
603-321-1145
Menarini-Stemline
Lisa Olender
Director of Oncology Access for the Northeast Region
Cell: 908.202.6936.
Email: lolender@menarinistemline.com
Elizabeth Gugliotta
Associate Director Access & Reimbursement
Elizabeth.Gugliotta@novartis.com
Cell: 401-480-9905
Ph+ CML-CP | SCEMBLIX® (asciminib) Tablets | HCP
HR+/HER2- eBC & mBC Treatment | KISQALI® (ribociclib) | HCP
Novocure
Chris Kelly
Territory Manager
mobile: 603-608-6848
work: 603-531-8946
ckelly@novocure.com
Oncopeptides
Kelly Draveling
National Account Executive
kelly.draveling@oncopeptides.com
816-522-2032
PEPAXTO (melphalan flufenamide)
Pharmacosmos Therapeutics, Inc
Monoferric and Cosela
Ryan Schmalz
Field Reimbursement Manager, Northeast
Mobile: 516-351-3428
Monoferric Patient Solutions: www.monoferricpatientsolutionsportal.com
Monoferric Copay Program: www.monoferriccopay.com
Pharmacyclics
Jason Hart
Field Access Specialist – Northeast
Cell: 603-777-6362
Email: Jason.hart@abbvie.com
IMBRUVICA (ibrutinib) Patient Access & Support Services: www.imbruvicabyyourside.com
PharmaEssentia
Kevin Penner, PACS
Field Access Manager, Northeast
Cell: (860)227-3458
BESREMI: https://www.besremihcp.com/patient-support/
Pfizer
Julie Rogers, MBA, CRT, CPC
Field Reimbursement Director
Pfizer Oncology
860-422-0420
Julie.rogers@pfizer.com
Pfizer Patient Assistance:
Adcetris, Besponsa, Bosulif, Braftovi, Daurismo, Ibrance, Inlyta, Lorbrena, Mektovi, Mylotarg, Talzenna, Tivdak, Tukysa, Vizimpro, Xalkori
Reimbursement Support and Co-pay assistance only: Elrexfio, Nivestym, Nyvepria, Ruxience, Trazimera, Zirabev
Puma Biotechnology
Laurie Rosa, BSN RN OCN CBCN
603-401-0739
LRosa@pumabiotechnology.com
NERLYNX® (neratinib)
Regeneron
Stephanie Decker
Oncology Reimbursement Manager
203-293-5065
Stephanie.decker@regeneron.com
Products: Libtayo Surround and Lynozyfic Surround
Learn about LIBTAYO Surround® - LIBTAYO® (cemiplimab-rwlc)
LYNOZYFIC Surround™ - LYNOZYFIC™ (linvoseltamab-gcpt)
Rigel Pharmaceuticals
Kent Main
Senior Territory Business Manager
Me/NH/VT North Shore Mass.
207-841-5156 cell
kmain@rigel.com
Sandoz Biopharmaceuticals
Andrew Palsha
Reimbursement Policy Manager
508 735-1941
andrew.palsha@sandoz.com
https://www.sandozonesource.com/
Sanofi
Chris Ramsay
Key Account Manager: Northeast
Phone: 617-529-3998
Christopher.Ramsay@sanofi.com
Drug Names:
Sarclisa (isatuximab-irfc), Jevtana (Cabazitaxel), Elitek (Raspuricase)
Drug Names:
Cerezyme - imiglucerase
Cerdelga - eliglustat
https://www.careconnectpss.com/
Drug Names:
Rezurock-Belumosudil)
Secura Bio
Gynt Padegs
Cell: 716 998 9860
Copiktra (duvelisib)
https://securabio.com/patient-support-programs
Secura Care: 844-9SECURA (844-973-2872)
Servier
Wendy Poage
Patient Advocacy
Oncaspar, Asparlas, Tibsovo
Wendy.Poage@servier.com
617-335-7987
Tina Belcastro
Reimbursement Contact
tina.belcastro@servier.com
603-770-0647
For help with access and financial assistance, call 800-813-5905 or visit ServierOne.com.
ServierONE
Email; USPatientServices@servier.com;
1-844-409-1141 (Tibsovo)
1-800-813-5905 (All other Products)
Tibsovo (Ivosidenib)
Voranigo (Vorasidenib)
Asparlas (Calasparagase pegol-mknl)
Oncaspar (Pegaspargase)
Sobi
Jill Bowtruczyk
Regional Business Director- Northeast
Mobile: 978-833-5173
jill.bowtruczyk@sobi.com
www.sobi.com
Amanda Erickson (Ogsiveo ME, NH, MA)
Territory Business Manager
Email: Amanda.Erickson@springworkstx.com
Cell: 603-770-4039
AnnaMaria Sprague (Ogsiveo VT)
Territory Business Manager
Cell: 607-745-3482
Email: AnnaMaria.Sprague@springworkstx.com
Melissa Morris (Ogsiveo ME, MA)
Territory Business Manager
Cell: 774-291-1498
Email: Melissa.Morris@springworkstx.com
Mike Sullivan (Gomekli NH, VT)
Territory Business Manager
Cell: 203-247-3931
Email: Mike.Sullivan@springworkstx.com
Our Products: Ogsiveo/nirogacestat | Gomekli/mirdametinib
Patient Support Services: SpringWorks CareConnections™ Patient Support Program
Stemline, a Menarini Group Company
Angela Csaszar
Field Reimbursement Director, Northeast
Cell: 724-858-6285
Acsaszar@menarinistemline.com
Products: ORSERDU/ELZONRIS
Website: https://stemline.com/
Our product website are:
ORSERDU: https://www.orserdu.com/
ELZONRIS: https://www.elzonris.com/
Patient assistance website: https://stemlinearc.com/
Sumitomo
www.Orgovyxhcp.com
www.Smpa-pap.com
Melissa Burke (Maine, New Hampshire and Massachusetts)
908-884-5796 cell
Mike Rogers (Vermont)
315-559-8803 cell
Syndax Pharmaceuticals, Inc.
Michelle L. Vallee
Oncology Account Manager - Boston, MA; Maine; New Hampshire
mvallee@syndax.com
C. 207.229.6702
www.revuforj.com (revumenib) tablets
Bob Stewart
Director, Market Access
Taiho Oncology, Inc.
101 Carnegie Center, Suite 101
Princeton, NJ 08540
609 575-5169
rstewart@taihooncology.com https://www.taihooncologycopay.com/
Takeda
Deborah Looney
Field Access Director
Ph: 617-543-9736
deborah.looney@takeda.com
Takeda Oncology Here2Assist™
Teva Pharmaceutical Industries Ltd.
Kate Friday
Director Patient Services
Kate.Friday@tevapharm.com
973-214-8394
US ACT Parsippany, NJ
TG Therapeutics
Kelly Bucklen
401.261.5262
Ukoniq (Umbralisib)
Acredo Specialty Pharmacy Jeremy Boehm
Sr. Account Director
Accredo Specialty Pharmacy
M: 781-980-2179
F: 855-817-2712
jboehm@express-scripts.com
Lauren Pacheco
Oncology Account Manager
376 Northlake Blvd
Altamonte Springs, FL 32701
Desk: 888-292-0744 Ext 2998
Cell: 407-721-1162
Fax: 800-269-5493
Lpacheco@Bioplusrx.com
Diplomat Specialty Pharmacy
Yakini Brown
Pharmacy Liaison
P. 810.768.9115
F. 810.262.0261
ybrown@diplomat.is
Foundation Medicine
Bill Walsh
Senior Account Executive | New England
C: 603.391.8174
Client Services: 888.988.3639
Foundation Medicine, Inc.
150 Second Street, Cambridge, MA 02141
bwalsh@foundationmedicine.comLast updated 10/25 - ES
Northern New England Clinical Oncology Society
P.O. Box 643
Sandown, NH 03873-0643
Telephone (603) 887-1948
info@nnecos.org
This website brought to you by:
